Furthermore, our previous studies demonstrated that BAP1, a novel upstream positive regulator of KLF5 in breast cancer, contributes to ESCC cells proliferation and migration through enhancing KLF5 expression and its downstream genes, including Cyclin D1 and FGF-BP1 [16]. The gene discussed is KLF5; the disease is breast carcinoma.